Nektar Therapeutics (NKTR)
NASDAQ: NKTR
· Real-Time Price · USD
27.24
0.55 (2.06%)
At close: Aug 15, 2025, 3:59 PM
26.80
-1.62%
After-hours: Aug 15, 2025, 07:25 PM EDT
Nektar Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 74.93M | 87.25M | 98.43M | 93.14M | 93.16M | 90.17M | 90.12M | 88.26M | 87.74M | 88.83M | 92.06M | 95.04M | 96.34M | 103.08M | 101.91M | 100.36M | 105.47M | 125.99M |
Cost of Revenue | 13.05M | 22.58M | 30.69M | 29.99M | 37.99M | 35.24M | 33.77M | 32.72M | 25.26M | 23.38M | 21.64M | 21.57M | 21.9M | 24.46M | 24.9M | 23.06M | 23.32M | 21.42M |
Gross Profit | 62.31M | 65.1M | 67.74M | 63.15M | 55.17M | 54.92M | 56.35M | 55.54M | 62.48M | 65.45M | 70.42M | 73.48M | 74.43M | 78.63M | 77.01M | 77.3M | 82.16M | 104.57M |
Operating Income | -100.76M | -114.31M | -105.2M | -26.8M | -25.96M | -26.78M | -126.06M | -259.7M | -263.67M | -259.86M | -240.24M | -312.26M | -388.38M | -451.8M | -446.1M | -443.91M | -433.37M | -400.87M |
Interest Income | 11.22M | 13.15M | 14.5M | 16.51M | 17.95M | 18.89M | 19.01M | 17.18M | 14.36M | 10.61M | 6.67M | 3.72M | 1.8M | 1.55M | 2.57M | 4.22M | 7M | 11.34M |
Pretax Income | -115.81M | -128.73M | -119.2M | -168.31M | -177.16M | -176.01M | -276.26M | -290.69M | -304M | -411.8M | -364.98M | -454.09M | -524.48M | -490.67M | -523.28M | -494.71M | -473.68M | -428.37M |
Net Income | -122.27M | -133.04M | -118.96M | -168.3M | -177.08M | -175.84M | -276.06M | -293.67M | -306.88M | -414.82M | -368.2M | -454.15M | -524.81M | -491.26M | -523.84M | -495.39M | -474.27M | -428.76M |
Selling & General & Admin | 77.51M | 80.95M | 76.75M | 76.94M | 79.13M | 76.48M | 77.42M | 82.04M | 83.42M | 86.08M | 92.33M | 102.54M | 109.47M | 118.5M | 122.84M | 117.84M | 115.35M | 110.14M |
Research & Development | 124.14M | 123.98M | 120.91M | 122.11M | 111.14M | 111.1M | 114.16M | 118.96M | 128.48M | 141.54M | 218.32M | 283.2M | 353.35M | 411.92M | 400.27M | 403.38M | 400.17M | 395.3M |
Other Expenses | -38.81M | -25.53M | -24.72M | 14.31M | 25.62M | 12.34M | 109.05M | 109.05M | 97.69M | 97.69M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 162.84M | 179.4M | 172.94M | 213.35M | 215.89M | 199.92M | 300.63M | 310.05M | 309.6M | 325.31M | 310.66M | 385.73M | 462.81M | 530.42M | 523.11M | 521.22M | 515.52M | 505.44M |
Interest Expense | 26.54M | 27.55M | 28.11M | 24.83M | 24.72M | 24.46M | 25.33M | 25.67M | 26.71M | 27.79M | 28.91M | 29.84M | 35.69M | 41.55M | 47.31M | 47.37M | 42.99M | 37.24M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 175.7M | 201.55M | 203.63M | 243.34M | 253.88M | 235.16M | 334.4M | 342.77M | 334.86M | 348.69M | 332.29M | 407.3M | 484.72M | 554.88M | 548.01M | 544.27M | 538.84M | 526.86M |
Income Tax Expense | -386K | -152K | -239K | -9K | -79K | -172K | -200K | 2.97M | 2.88M | 3.03M | 3.21M | 67K | 334K | 591K | 557K | 689K | 598K | 385K |
Shares Outstanding (Basic) | 14.09M | 14.06M | 13.98M | 13.95M | 13.92M | 12.98M | 12.74M | 12.69M | 12.64M | 12.59M | 12.55M | 12.51M | 12.45M | 12.39M | 12.33M | 12.27M | 12.18M | 12.09M |
Shares Outstanding (Diluted) | 14.09M | 14.06M | 14.24M | 13.95M | 13.92M | 12.98M | 12.74M | 12.69M | 12.64M | 12.59M | 12.55M | 12.51M | 12.45M | 12.39M | 12.33M | 12.27M | 12.18M | 12.09M |
EPS (Basic) | -8.71 | -9.52 | -8.73 | -12.55 | -13.5 | -13.79 | -21.91 | -23.41 | -24.45 | -33.15 | -29.55 | -36.6 | -42.45 | -40.05 | -42.9 | -40.8 | -39.45 | -35.85 |
EPS (Diluted) | -8.72 | -9.53 | -8.74 | -12.55 | -13.5 | -13.79 | -21.91 | -23.41 | -24.45 | -33.15 | -29.55 | -36.6 | -42.45 | -40.05 | -42.9 | -40.8 | -39.45 | -35.85 |
EBITDA | -89.75M | -97.97M | -86.7M | -137.77M | -146.03M | -144.43M | -243.11M | -247.28M | -258.56M | -364.01M | -314.64M | -412.11M | -475.71M | -435.94M | -462.97M | -433.38M | -417.1M | -377.91M |
EBIT | -89.27M | -101.18M | -91.09M | -143.48M | -152.44M | -151.55M | -250.92M | -265.02M | -277.29M | -384.01M | -336.07M | -424.25M | -488.79M | -449.13M | -475.97M | -447.34M | -430.68M | -391.13M |
Depreciation & Amortization | 1.97M | 3.21M | 4.39M | 5.71M | 6.41M | 7.12M | 7.82M | 8.52M | 9.5M | 10.77M | 12.2M | 12.14M | 13.08M | 13.19M | 13M | 13.96M | 13.58M | 13.22M |